Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy
An essential step for cancer vaccination is to break the immunosuppression and elicit a tumor-specific immunity. A major hurdle against cancer therapeutic vaccination is the insufficient immune stimulation of the cancer vaccines and lack of a safe and efficient adjuvant for human use. We discovered...
Guardado en:
Autores principales: | Aihua Wu, Yingzhi Chen, Hairui Wang, Ya Chang, Meng Zhang, Pengfei Zhao, Yisi Tang, Qin Xu, Zhuangzhi Zhu, Yang Cao, Yongzhuo Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eda5c3f270624e1ebbeea6bba12704d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines
por: Francesco Borriello, et al.
Publicado: (2018) -
Polyethylenimine-based micro/nanoparticles as vaccine adjuvants
por: Shen C, et al.
Publicado: (2017) -
Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice
por: Sadeghi Z, et al.
Publicado: (2020) -
Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection
por: Minami Nagai, et al.
Publicado: (2021) -
Alum Pickering Emulsion as Effective Adjuvant to Improve Malaria Vaccine Efficacy
por: Qiuting Chen, et al.
Publicado: (2021)